Clinical Trial Update: Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating temozolomide and carmustine for patients with anaplastic glioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Glioma

Drugs mentioned

• Carmustine (carmustine)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED